Dementia. Alzheimers disease
Conditions
Interventions
Intervention 1: Control group: In this group, 36 eligible patients were randomly selected. Participants received placebo capsules prepared by the pharmacist in charge of the study. The placebo consist
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Age
65 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age 65 to 80 years Being literate Alzheimer's disease and definitive diagnosis Consent to participate in the study
Exclusion criteria
Exclusion criteria: Severe cognitive impairment (MMSE score less than 10) severe heart failure (EF below 40)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of Addenbrooke’s Cognitive Examination. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Addenbrooke's test.;Gamma-secretase enzyme levels. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: ELISA test.;Working Memory Index. Timepoint: Before the intervention begins and after the intervention ends. Method of measurement: Wechsler Memory Test WMS-IV. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactOmid Ehsanzade
Ardabil University of Medical Sciences
Outcome results
None listed